Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 8
Results: 20
Mid-year at the FDA highlights permanentproblem.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 637, doi. 10.1038/nrd1486
- By:
- Publication type:
- Article
Calls for full disclosure of clinical trials.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 635, doi. 10.1038/nrd1485
- By:
- Publication type:
- Article
Recombinant biologics for treatment of bleeding disorders.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 684, doi. 10.1038/nrd1443
- By:
- Publication type:
- Article
Case history: A new oral anticoagulant: the 50-year challenge.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 649, doi. 10.1038/nrd1466
- By:
- Publication type:
- Article
Fragment-based lead discovery.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 660, doi. 10.1038/nrd1467
- By:
- Publication type:
- Article
Drug repositioning: identifying and developing new uses for existing drugs.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 673, doi. 10.1038/nrd1468
- By:
- Publication type:
- Article
Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 695, doi. 10.1038/nrd1469
- By:
- Publication type:
- Article
Can the pharmaceutical industry reduce attrition rates?
- Published in:
- 2004
- By:
- Publication type:
- review
From the analyst's couch: Statin switch to OTC.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 641, doi. 10.1038/nrd1471
- By:
- Publication type:
- Article
Fresh from the pipeline: Tiotropium bromide.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 643, doi. 10.1038/nrd1472
- By:
- Publication type:
- Article
Nuclear receptors: Growing concern for tamoxifen.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 647, doi. 10.1038/nrd1474
- By:
- Publication type:
- Article
Autoimmune diabetes: NKG2D receptor: a therapeutic target?
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 646, doi. 10.1038/nrd1475
- By:
- Publication type:
- Article
Anticancer drugs: Taking out the chaperone.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 646, doi. 10.1038/nrd1476
- By:
- Publication type:
- Article
Statins: Target audience.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 648, doi. 10.1038/nrd1477
- By:
- Publication type:
- Article
Antiviral Drugs: Third strike against HIV enzymes.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 645, doi. 10.1038/nrd1480
- By:
- Publication type:
- Article
Hoping for the mother of all mergers.
- Published in:
- 2004
- Publication type:
- Editorial
Training academic chemists for industry.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 719, doi. 10.1038/nrd1483
- By:
- Publication type:
- Article
Francis S. Collins.
- Published in:
- 2004
- By:
- Publication type:
- Interview
Reach-through claims: how far a reach?
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 639, doi. 10.1038/nrd1491
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 8, p. 648, doi. 10.1038/nrd1479
- Publication type:
- Article